Chemicals & Advanced Materials Global On demand · 24-48h

Global Hawthorn Leaf Flavonoids (HLF) Market Strategic Research Report

Global Hawthorn Leaf Flavonoids (HLF) Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Hawthorn Leaf Flavonoids (HLF) Market
$27.552025
5.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Dry Extract, Quantified Liquid Extract, Other

By Application: Pharmaceuticals, Dietary Supplements, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Indena, Euromed, Finzelberg, Dr. Willmar Schwabe, Hunan Nutramax, Wellgreen Technology, Shaanxi Xintianyu Biotechnology, Changsha Comext Biotech, Shaanxi KBC Biotech, Summit Ingredients

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 93 pages
Market size 2025
$27.55
Million USD
Forecast CAGR
5.3%
2025-2032
Forecast 2032
$39.5
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Hawthorn Leaf Flavonoids (HLF) market size is predicted to grow from US$ 27.55 million in 2025 to US$ 39.14 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.

Hawthorn Leaf Flavonoids (HLF) refers to a flavonoid-rich fraction obtained from hawthorn leaves (Crataegus spp., and in some Asian supply chains specifically Crataegus pinnatifida leaves). It is a mixture of flavonoids and flavonoid glycosides, commonly represented by vitexin derivatives, vitexin, rutin, and hyperoside; commercial materials are often standardized/quantified by “total flavonoids” or by multi-marker assays.

Upstream raw material is primarily dried hawthorn leaves (and in the EU herbal drug system often hawthorn leaf with flower, Crataegi folium cum flore), requiring botanical authentication and consistent harvesting/quality control of the plant material. Downstream, flavonoid-standardized hawthorn leaf preparations are used as traditional herbal medicinal products for specified traditional indications, and hawthorn leaf flavonoids are also widely used in herbal/dietary supplement products.

In 2025, global sales of Hawthorn Leaf Flavonoids (HLF) reached approximately 1,083 tons, with an average global market price of around US$ 26/kg. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 20% to 40%.

Global key Hawthorn Leaf Flavonoids (HLF) players cover Indena, Euromed, Finzelberg, Dr. Willmar Schwabe, Hunan Nutramax, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hawthorn Leaf Flavonoids (HLF) market?

What factors are driving Hawthorn Leaf Flavonoids (HLF) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hawthorn Leaf Flavonoids (HLF) market opportunities vary by end market size?

How does Hawthorn Leaf Flavonoids (HLF) break out by Type, by Application?

This report presents a comprehensive overview of the global Hawthorn Leaf Flavonoids (HLF) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Dry Extract
  • Quantified Liquid Extract
  • Other

Segment by Flavonoid Content Tier

  • Hyperoside≥2.5%
  • Hyperoside≥6.0%
  • Other

Segment by Botanical Source

  • Hawthorn
  • Crataegus Pinnatifida

Segment by Application

  • Pharmaceuticals
  • Dietary Supplements
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Hawthorn Leaf Flavonoids (HLF) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceuticals, Dietary Supplements, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Hawthorn Leaf Flavonoids (HLF) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$27.55
2025
Forecast
$39.5
2032
CAGR
5.3%
2025–2032
Regions
5
global
Key companies
IndenaEuromedFinzelbergDr. Willmar SchwabeHunan NutramaxWellgreen TechnologyShaanxi Xintianyu BiotechnologyChangsha Comext Biotech
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Dry ExtractQuantified Liquid ExtractOther
By Application
PharmaceuticalsDietary SupplementsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Dry Extract
  • 3.1.3 Quantified Liquid Extract
  • 3.1.4 Other
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceuticals
  • 4.1.3 Dietary Supplements
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Indena
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Euromed
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Finzelberg
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Dr. Willmar Schwabe
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Hunan Nutramax
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Wellgreen Technology
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Shaanxi Xintianyu Biotechnology
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Changsha Comext Biotech
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Shaanxi KBC Biotech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Summit Ingredients
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Hawthorn Leaf Flavonoids (HLF) market?
The global Hawthorn Leaf Flavonoids (HLF) market is estimated at US$ 27.55 million in 2025 (base year) and is projected to reach US$ 39.14 million by 2032.
How fast is the Hawthorn Leaf Flavonoids (HLF) market expected to grow?
The market is expected to grow at a CAGR of 5.3% from 2026 to 2032, expanding from US$ 27.55 million in 2025 to US$ 39.14 million in 2032, roughly 1.4 times its base-year value.
What does the Hawthorn Leaf Flavonoids (HLF) market cover?
Hawthorn Leaf Flavonoids (HLF) refers to a flavonoid-rich fraction obtained from hawthorn leaves (Crataegus spp., and in some Asian supply chains specifically Crataegus pinnatifida leaves). It is a mixture of flavonoids and flavonoid glycosides, commonly represented by vitexin derivatives, vitexin, rutin, and hyperoside; commercial materials are often standardized/quantified by “total flavonoids” or by multi-marker assays.
What are the main segments of the Hawthorn Leaf Flavonoids (HLF) market by type?
By type, the market is segmented into Dry Extract, Quantified Liquid Extract and Other.
Which applications drive demand in the Hawthorn Leaf Flavonoids (HLF) market?
Key applications covered include Pharmaceuticals, Dietary Supplements and Other.
Who are the key players in the Hawthorn Leaf Flavonoids (HLF) market?
Key players profiled include Indena, Euromed, Finzelberg, Dr. Willmar Schwabe, Hunan Nutramax, Wellgreen Technology, Shaanxi Xintianyu Biotechnology and Changsha Comext Biotech, among 10 companies covered in total.
Which regions and countries are covered for Hawthorn Leaf Flavonoids (HLF)?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Hawthorn Leaf Flavonoids (HLF) market?
What factors are driving Hawthorn Leaf Flavonoids (HLF) market growth, globally and by region?
Who should buy the Hawthorn Leaf Flavonoids (HLF) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceuticals, Dietary Supplements and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Hawthorn Leaf Flavonoids (HLF) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.